--- title: What Is GMP in Pharmaceutical Manufacturing? A Distributor and Pharmacist Guide (Nigeria) url: "https://www.dizpharm.org/blog/what-is-gmp-pharmaceutical-manufacturing-nigeria" category: Quality & Compliance published: 2026-05-23 updated: 2026-05-23 readTime: 11 min read description: GMP (Good Manufacturing Practice) explained for Nigerian pharmacy buyers and distributors — what NAFDAC audits, the ten pillars of GMP, how the inspection actually works, and red flags that signal a manufacturer is not truly GMP-compliant. source: Dizpharm Nigeria Limited --- # What Is GMP in Pharmaceutical Manufacturing? A Distributor and Pharmacist Guide - **URL**: https://www.dizpharm.org/blog/what-is-gmp-pharmaceutical-manufacturing-nigeria - **Category**: Quality & Compliance - **Published**: 2026-05-23 - **Read time**: 11 min read **Summary:** GMP (Good Manufacturing Practice) explained for Nigerian pharmacy buyers and distributors — what NAFDAC audits, the ten pillars of GMP, how the inspection actually works, and red flags that signal a manufacturer is not truly GMP-compliant. **Key takeaways:** - GMP is not a logo — it is a continuous, audited operating standard NAFDAC inspects on-site, on a recurring cycle. - NAFDAC GMP inspections cover ten functional areas: premises, personnel, equipment, materials, production, quality control, documentation, complaints, recalls and self-inspection. - A genuinely GMP-compliant factory keeps batch records for every product run; ask to see one before signing a supply agreement. - Distributors and pharmacists can verify GMP status by checking NAFDAC registration, requesting the most recent inspection summary, and visiting the facility in person. - The cost of buying from a non-GMP manufacturer shows up as failed quality (split blisters, dose variation, short shelf life) and regulatory exposure. ## GMP in one paragraph Good Manufacturing Practice (GMP) is the international standard that defines how pharmaceuticals must be produced so that every pack a patient swallows is identical to every other pack of the same product. In Nigeria the standard is enforced by NAFDAC under the WHO GMP framework, and a manufacturer cannot lawfully produce regulated pharmaceuticals without being GMP-compliant. "GMP certified" is shorthand for "has passed a NAFDAC inspection and is operating under documented procedures the agency has approved" — not a one-time certificate but a continuous status that can be suspended or withdrawn. ## Why GMP exists — and why it matters to distributors Without GMP, two packs of the same labelled product could contain different active ingredient doses, different impurity profiles, or different stability characteristics. A patient taking the lower-dose pack might fail to recover; one taking the higher-dose pack might be harmed. For distributors this translates into: - Product consistency — every carton you sell behaves like every other carton, which protects your customer relationships. - Shelf-life reliability — GMP-compliant products carry honest expiry dates because the stability data underpinning them was generated under controlled conditions. - Regulatory cover — if a complaint reaches NAFDAC, your manufacturer's batch records can trace the product back to a specific production run, which protects everyone in the supply chain. - Recall capability — when something does go wrong (it occasionally does, even at the best plants), a GMP-compliant manufacturer can identify and recall a specific batch instead of pulling the whole product. If a manufacturer cannot give you a batch number, expiry date and matching invoice for every consignment, they cannot meaningfully claim GMP compliance. ## The ten pillars NAFDAC inspects NAFDAC GMP inspections at a Nigerian pharmaceutical factory cover ten functional areas. Each is scored, and a single critical failure in any area can suspend production. 1. Premises and layout — physical separation of production areas, controlled environmental conditions (temperature, humidity, particulate counts in tablet halls), one-way personnel and material flow to prevent cross-contamination. 2. Personnel — qualified pharmacists supervising production, documented training records for every employee, health checks, gowning and hygiene protocols. 3. Equipment — calibrated, maintained, qualified for the products being made. Cleaning validated between products. Logbooks for every machine. 4. Raw materials — every batch of incoming API and excipient tested against pharmacopoeial specifications before release to production. Suppliers are audited and approved. 5. Production — written, approved master formulae for every product. Each batch produced exactly to that formula, with every step recorded in real time. 6. Quality Control (QC) — independent QC laboratory testing every batch before release. Assay, dissolution, uniformity, microbial limits, identity. Retained samples for every batch. 7. Documentation — Standard Operating Procedures (SOPs) for every activity. Batch Manufacturing Records (BMRs) for every batch. Validation reports for every process. Documents controlled and auditable. 8. Complaints handling — system to receive, investigate and respond to product complaints from the market. 9. Recalls — documented, tested ability to retrieve a specific batch from the market within a defined time. 10. Self-inspection — the manufacturer audits itself on a defined cycle and corrects deficiencies before NAFDAC arrives. ## How a NAFDAC GMP inspection actually runs A typical NAFDAC GMP audit at a Nigerian pharmaceutical plant looks something like this: - A team of NAFDAC inspectors (typically 2-4 people including pharmacists and QA specialists) arrives on a scheduled or unannounced visit. - Opening meeting with the company superintendent pharmacist and QA head. - Facility walkthrough — tablet hall, granulation, packaging, warehouse, QC lab, change rooms. - Document review — SOPs, BMRs for recent batches, validation files, training records, equipment logs, complaint files, recall records, self-inspection reports. - Personnel interviews — operators are asked to demonstrate procedures they should know by memory. - Sample collection — finished product samples may be taken for independent QC testing at a NAFDAC lab. - Closing meeting — findings are categorised (critical, major, minor) and a corrective-action timeline is agreed. The inspection cycle is typically every 2-3 years for established plants, with follow-up visits if findings need verification. ## How distributors can verify GMP status before signing You do not need to be a regulator to verify a manufacturer's GMP status. Five practical checks: 1. Confirm the company has NAFDAC manufacturer registration — every NAFDAC-registered product has a registration number traceable to a registered manufacturer. Our verification guide covers exactly how. 2. Ask for a sample Batch Manufacturing Record (BMR) — a real GMP-compliant manufacturer can show you a redacted BMR for a recent batch on request. If they cannot or will not, walk away. 3. Visit the facility — Nigerian pharmaceutical plants generally welcome serious distributor visits. A GMP-compliant plant will have visible gowning, controlled access, an on-site QC lab, and a superintendent pharmacist who can speak fluently about their batch release process. 4. Request the most recent NAFDAC inspection summary — manufacturers should be willing to share at least a redacted overview confirming when their last inspection was and whether they hold current GMP status. 5. Check product batch traceability — every pack you receive should carry a batch number that the manufacturer can map back to a specific production date, production line, raw material lot and QC release certificate. ## Red flags that suggest a manufacturer is not genuinely GMP-compliant - Refusal to allow a facility visit or to share basic GMP documentation. - Inconsistent batch number formats, missing expiry dates, or batch numbers that cannot be traced back. - Products sold without a NAFDAC registration number printed on the immediate container. - Quality problems showing up at the pack level — broken blisters, smudged printing, inconsistent tablet appearance between cartons of the same SKU. - Pricing that is suspiciously below the rest of the market for an identical generic — at a certain point this signals cut corners somewhere. ## GMP at Dizpharm Dizpharm Nigeria Limited has operated its Ibusa, Delta State facility under NAFDAC + WHO GMP since 1986. The plant runs separate tablet, liquid and packaging lines under documented SOPs, an on-site QC laboratory tests every batch before release, and every product carries a NAFDAC registration number printed on the immediate container. Distributors are welcome to visit. See our [statistics page](https://www.dizpharm.org/about/statistics) for the verifiable operational figures, or contact us on WhatsApp to arrange a facility tour. ## FAQ **Q: Is "GMP certified" the same as "NAFDAC registered"?** No — they are related but separate. NAFDAC registers individual products, and the manufacturer producing those products must hold current GMP status to keep them registered. A product can lose its NAFDAC registration if its manufacturer falls out of GMP compliance. **Q: How often does NAFDAC re-inspect a GMP-compliant manufacturer?** The typical cycle is every 2-3 years for an established, well-rated plant, with shorter intervals if there are open findings or recent product complaints. NAFDAC may also conduct unannounced visits. **Q: Can a distributor be held liable for selling products from a non-GMP manufacturer?** Yes. Nigerian distributors are required to source only from NAFDAC-registered manufacturers and authorised channels. Selling unregistered or substandard products is a regulatory offence and can result in product seizure, fines, and criminal prosecution. **Q: What is the difference between GMP and ISO 9001?** ISO 9001 is a general quality-management framework applicable to any industry; GMP is the pharmaceutical-specific standard enforced by NAFDAC. A pharmaceutical manufacturer may hold both, but only GMP is mandatory. **Q: How do I see the Dizpharm GMP credentials?** Dizpharm holds current NAFDAC + WHO GMP status for its Ibusa facility. Distributor partners can request a facility visit, a redacted recent inspection summary, and sample Batch Manufacturing Records during the partner-onboarding process. ## Sources cited - [NAFDAC — National Agency for Food and Drug Administration and Control](https://nafdac.gov.ng/) - [NAFDAC Drug Registration Guidelines](https://nafdac.gov.ng/regulatory-resources/guidelines/) - [WHO — Good Manufacturing Practices for pharmaceutical products](https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications/norms-and-standards/guidelines/production) - [Pharmacists Council of Nigeria (PCN)](https://pcn.gov.ng/) - [WHO Model List of Essential Medicines](https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2023.02) --- *Source: Dizpharm Nigeria Limited — NAFDAC-certified pharmaceutical manufacturer since 1986. Canonical HTML at the URL above; this is the markdown variant for LLM ingestion. Linkable, citable, quotable with attribution.*